ABVC BioPharma, Inc. Warrant, Exercise Price, Decrease
ABVC BioPharma, Inc. (ABVC) reported Warrant, Exercise Price, Decrease of $0.75 per share for the 9-month period ending 2025-09-30, per its 10-Q/A filed 2026-03-03.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2026-03-03
- 2025-09-30: .
- 2025-06-30: Warrant, Exercise Price, Decrease 6 month $0.75.
- 2024-12-31: Warrant, Exercise Price, Decrease 1 month $117277.00.
- 2024-05-22: Warrant, Exercise Price, Decrease $0.75.
| Period end | Warrant, Exercise Price, Decrease | Warrant, Exercise Price, Decrease as first filed | Warrant, Exercise Price, Decrease 1 month | Warrant, Exercise Price, Decrease 6 month | Warrant, Exercise Price, Decrease 9 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.75 10-Q/A · filed 2026-03-03 | ||||
| 2025-06-30 | $0.75 10-Q · filed 2025-08-13 | ||||
| 2024-12-31 | $117277.00 10-K · filed 2026-03-03 | ||||
| 2024-05-22 | $0.75 10-Q · filed 2025-04-30 | ||||
| 2023-02-23 | $10.50 10-Q/A · filed 2026-03-03 | $1.05 10-Q · filed 2024-05-17 | |||
| 2020-11-19 | $2.25 10-Q · filed 2022-11-14 |